Literature DB >> 28394869

A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement.

Joseph C Y Chan1,2, Connie I Diakos1,3,2, David L H Chan3, Alexander Engel4,2, Nick Pavlakis1,2, Anthony Gill5,2, Stephen J Clarke1,3,2.   

Abstract

OBJECTIVE: To characterize the longitudinal course of the systemic inflammatory response (SIR) throughout the perioperative period. To investigate whether postoperative changes in the neutrophil-to-lymphocyte ratio (NLR) or lymphocyte-to-monocyte ratio (LMR) when compared with preoperative levels ('conversion') are associated with survival differences in colorectal cancer patients undergoing resection.
BACKGROUND: Recent evidence suggests that preoperative measurements of markers of the SIR including the NLR and LMR are prognostic. However, a few data exist evaluating longitudinal changes in the SIR especially in regards to their association with surgical interventions, optimal timing of assessment, and their effect on patient survival.
METHODS: Data from 6 hospitals from January 1998 to December 2012 were retrospectively collected. We examined 2280 patients with complete data. For the subgroup analysis investigating conversion, we examined 587 patients with full preoperative and postoperative data from 21 to 56 days postoperative. Patients were stratified into 4 groups for analysis of conversion in a multivariate Cox-regression model.
RESULTS: A longitudinal profile for the perioperative NLR and LMR was clearly characterized identifying an optimal period of remeasurement at 21 to 56 days postoperation. In multivariate analysis both NLR change group (P < 0.001) and LMR change group (P < 0.001) were independently associated with overall survival. For both biomarkers, patients with both a low preoperative and postoperative inflammatory state had the best survival. A change from the preoperative to postoperative inflammatory state was associated with a survival difference.
CONCLUSIONS: This study characterizes the perioperative SIR profile and provides evidence for the remeasurement of SIR biomarkers postoperatively at 21 to 56 days for further prognostication.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28394869     DOI: 10.1097/SLA.0000000000002251

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  12 in total

1.  Preoperative Leucocyte-Based Inflammatory Scores in Patients with Colorectal Liver Metastases: Can We Count on Them?

Authors:  Aurélien Dupré; Robert P Jones; Rafael Diaz-Nieto; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

2.  The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma.

Authors:  Yoshiyuki Matsui; Ayumu Matsuda; Aiko Maejima; Yasuo Shinoda; Eijiro Nakamura; Motokiyo Komiyama; Hiroyuki Fujimoto
Journal:  Int J Clin Oncol       Date:  2022-03-23       Impact factor: 3.402

3.  Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer.

Authors:  Wenjing Zhao; Guoxin Mao; Yueyue Zhu
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 4.  Does postoperative inflammation or sepsis generate neutrophil extracellular traps that influence colorectal cancer progression? A systematic review.

Authors:  Georgia M Carroll; Grace L Burns; Joel A Petit; Marjorie M Walker; Andrea Mathe; Stephen R Smith; Simon Keely; Peter G Pockney
Journal:  Surg Open Sci       Date:  2020-01-23

Review 5.  Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy.

Authors:  Hans Raskov; Adile Orhan; Shruti Gaggar; Ismail Gögenur
Journal:  Oncogenesis       Date:  2022-05-03       Impact factor: 6.524

6.  Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma.

Authors:  Chunyan Zhou; Dong Duan; Shuang Liu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

7.  Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.

Authors:  Nigel P Murray; Ricardo Villalon; Dan Hartmann; Patricia Maria Rodriguez; Socrates Aedo
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

8.  Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer.

Authors:  Janette L Vardy; Haryana Mary Dhillon; Gregory R Pond; Corrinne Renton; Stephen J Clarke; Ian F Tannock
Journal:  ESMO Open       Date:  2018-02-14

9.  Pretreatment albumin globulin ratio has a superior prognostic value in laryngeal squamous cell carcinoma patients: a comparison study.

Authors:  Tao Zhou; Shi-Tong Yu; Wan-Zhi Chen; Rong Xie; Ji-Chun Yu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

10.  Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer.

Authors:  Jung Hyun Kim; Jae-Hoon Lee; Hye Sun Lee; Su-Jin Shin; Eun Jung Park; Eun-Suk Cho; Seung Hyuk Baik; Kang Young Lee; Jeonghyun Kang
Journal:  J Inflamm Res       Date:  2021-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.